$HRMY: Harmony Biosciences Files Form 8-K/A on Planned CEO Transition to COO

$HRMY

$HRMY – Harmony Biosciences Files Form 8-K/A on Planned CEO Transition to COO Peter Anastasiou

Harmony Biosciences Holdings, Inc.

2026-10-30 00:00:00 UTC · SEC_8K · All $HRMY

? Neutral AI Sentiment (-0.5 / 10)

Form 8-K/A details executive leadership succession at Harmony Biosciences.
COO Peter Anastasiou appointed President & CEO and Class I Director.
Former CEO Jeffrey Dayno to provide advisory consulting services through January 2028.